Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin

BJU International

Volumn 105, Issue 6, 2010, Pages 789-794

  Ray, Eleanor R ^a   Chatterton, Kathryn ^a   Khan, M Shamim ^a   Chandra, Ashish ^b   Thomas, Kay ^a   Dasgupta, Prokar ^a   O'Brien, Tim S ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bacille Calmette Gu rin; Bladder; Carcinoma; Fluorescence; Hexylaminolaevulinate

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; DYSPLASIA; FALSE POSITIVE RESULT; FEMALE; GROUPS BY AGE; HEXYLAMINOLAEVULINATE FLUORESCENCE CYSTOSCOPY; HUMAN; HYPERPLASIA; INTRAPROSTATIC TRANSITIONAL CELL CARCINOMA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY; WHITE LIGHT;

ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENTS; BCG VACCINE; CYSTOSCOPY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOSENSITIZING AGENTS; URINARY BLADDER NEOPLASMS;

EID: 77649253473     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08839.x     Document Type: Article

References (25)

1. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004 171 : 135 138
2. Fradet Y, Grossman HB, Gomella L et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007 178 : 68 73 (Pubitemid 46908730)
3. Grossman HB, Gomella L, Fradet Y et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007 178 : 62 7
4. Jichlinski P, Guillou L, Karlsen SJ et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer - a multicenter study. J Urol 2003 170 : 226 229
5. Jocham D, Witjes F, Wagner S et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005 174 : 862 6
6. Koenig F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int 1999 83 : 129 135
7. Riedl CR, Plas E, Pfluger H. Fluorescence detection of bladder tumors with 5-amino-levulinic acid. J Endourol 1999 13 : 755 759
8. Jeon SS, Kang I, Hong JH, Choi HY, Chai SE. Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms. J Endourol 2001 15 : 753 759
9. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996 155 : 105 109
10. De Dominicis C, Liberti M, Perugia G et al. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity. Urology 2001 57 : 1059 1062
11. Stenzl AS, Roessler WR, Fradet YF et al. Hexvix® fluorescence cystoscopy improves detection and resection of papillary bladder cancer and reduces early recurrence: a multicentre, prospective, randomized study. EAU Congress, Stockholm, Sweden, 2009 : 373
12. PhotoCure ASA. Hexvix: powder for solution for intravesical use. Hexyl aminolevulinate hydrochloride. Investigator's Brochure. Oslo, Norway
13. Loidl W, Schmidbauer J, Susani M, Marberger M. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 2005 47 : 323 326
14. Witjes JA, Moonen PM, van der Heijden AG. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study. Eur Urol 2005 47 : 319 322
15. Babjuk M, Soukup V, Petrik R, Jirsa M, Dvoracek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int 2005 96 : 798 802
16. Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 2001 165 : 1121 1123
17. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 6th edn. New Jersey : John Wiley, 2002
18. Mostofi FK, Sobin LH, Torloni H. International Histological Classification of Tumours. Geneva : World Health Organisation, 1973
19. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 1448
20. Filbeck T, Roessler W, Knuechel R, Straub M, Kiel HJ, Wieland WF. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol 1999 13 : 117 121
21. Jichlinski P, Forrer M, Mizeret J et al. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 1997 20 : 402 408
22. Grimbergen MC, van Swol CF, Jonges TG, Boon TA, van Moorselaar RJ. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 2003 44 : 51 6
23. Lamm DL, Blumenstein BA, Crissman JD et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 2000 163 : 1124 1129
24. Guy L, Savareux L, Molinie V, Botto H, Boiteux JP, Lebret T. Should bladder biopsies be performed routinely after bacillus Calmette-Guerin treatment for high-risk superficial transitional cell cancer of the bladder? Eur Urol 2006 50 : 516 520
25. Zaak D, Frimberger D, Stepp H et al. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection. J Urol 2001 166 : 1665 1668